Analyzing Horizon Therapeutics’s Unusual Options Activity
Horizon Therapeutics (NASDAQ:HZNP) shares experienced unusual options activity on Wednesday. The stock price moved up to $108.74 following the option alert.
Horizon Therapeutics Stock Shoots Higher As Relaunch Of Thyroid Eye Disease Med Boosts Q2 Sales; Raises FY21 Outlook
Horizon Therapeutics plc (NASDAQ:HZNP) stock is gaining amid second-quarter solid earnings after reporting adjusted EPS of $1.62, almost tripled from…
Horizon Therapeutics Earlier Reported Q2 EPS $1.62 Beats $0.88 Estimate, Sales $832.55M Beat $685.03M Estimate
Horizon Therapeutics (NASDAQ:HZNP) reported quarterly earnings of $1.62 per share which beat the analyst consensus estimate of $0.88 by 84.09 percent. This is a 305 percent increase over earnings of $0.40 per share from
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.
Horizon Therapeutics: Q2 Earnings Insights
Shares of Horizon Therapeutics (NASDAQ:HZNP) moved higher by 9.0% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 305.00% year over year to $1.62, which beat the estimate of $0.88.
The Daily Biotech Pulse: Pfizer’s Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam’s Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Stocks That Hit 52-Week Highs On Thursday
Thursday's morning session saw 167 companies set new 52-week highs.